Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Study Phase : Discovery
Sponsor : Ocular Therapeutix
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under terms of the agreement, the collaboration between Ocular Therapeutix and Mosaic focuses on the discovery and development of novel complement inhibitors with extended duration of activity.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 29, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Discovery
Sponsor : Ocular Therapeutix
Deal Size : Undisclosed
Deal Type : Collaboration